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Objectives: to evaluate the impact of the carotid plaque type on recurrent carotid stenosis, future cardiovascular events and
patients' survival.
Design: open prospective study.
Patients and methods: three hundred and eight patients who underwent a total of 338 carotid endarterectomies were
included in the study. All of the patients were evaluated postoperatively with clinical examination and colour duplex 1
month after the operation and every 6 months thereafter. Mean duration of follow-up was 63 months (range: 12±144). Eight
patients (3%) were lost to follow-up. Restenoses, cardiovascular events and deaths were recorded and analysed with regard
to the traditional risk factors and the ultrasonographic characteristics of the plaques. Statistical analysis was performed
using the Kaplan±Meier method, the log rank test and Cox regression analysis.
Results: cumulative restenosis rate at 10 years of follow-up was 21% and was associated with coronary artery disease
(p 0.01) and echolucent plaques (p 0.02). Life-table analysis showed a 10-year survival rate of 64% and a 10-year rate
of cardiovascular events of 41%. Hypertension (p 0.003), coronary artery disease (p 0.002) and echolucent plaques
(p 0.01) were associated with a higher incidence of cardiovascular events.
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The ultrasonographic characteristics of the carotid
plaques have been the focus of great interest over the
past decade. Based on their echogenicity, carotid
plaques were initially classified into four categories
by Gray-Weale et al.,1 with the subsequent addition
of a fifth category by Geroulakos et al.2 Several studies
have been performed thereafter, in order to explore
the clinical implications and the pathogenetic basis of
this classification. It has been shown that echolucent
plaques or plaques with grey scale median below 32
or 40 are associated with a higher incidence of cere-
brovascular symptoms2±9 and cerebral infarctions.9,10
Biochemical analyses have shown that echolucent
plaques are correlated with increased plasma levels
of triglyceride-rich lipoproteins,11 whereas histo-
logical studies have revealed that echolucency of
carotid plaques is associated with an increased lipid
content rendering them more vulnerable to rupture.7Please address all correspondence to: C. D. Liapis, 131, Vas. Sofias
Ave., 11521, Athens, Greece.
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1078±5884/02/030239 06 $35.00/0 # 2002 Elsevier Science Ltd. AlOn the contrary, echogenic plaques consist mainly of
fibrin and collagen, which makes them more stable.
Echogenicity of the carotid plaques has also been
related to various risk factors, such as age, gender,
arterial hypertension, diabetes mellitus, coronary
artery disease and smoking, with conflicting, how-
ever, results.7,12 More recently, echolucent carotid pla-
ques were associated with a higher rate of carotid
stenosis progression,13 while echogenic plaques were
correlated with a lower incidence of restenosis after
carotid endarterectomy.14
It seems that we have not yet recognised the full
range of clinical and pathologic implications of
the ultrasonographic characteristics of the carotid
plaques. In this context, we performed the following
open prospective study in order to determine whether
the ultrasonographic type of the carotid artery plaques
influences the rate of restenosis after carotid endarter-
ectomy as well as the incidence of future cardio-
vascular events. The initial idea was based on the
assumption that different plaque types reflect differ-
ent disease processes, which continue to progress
even after the local resection of the specific atheroma
located at the carotid bifurcation.l rights reserved.
Table 2. Pharmacological treatment at the day of the last follow-up
examination.
Drug Number %
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Three hundred and eight consecutive patients who
underwent carotid endarterectomy in our Department
between July 1988 and June 2000 were included in
our study. Of these patients, 278 underwent unilateral
and 30 bilateral carotid endarterectomy, always as a
two-stage procedure, leading to a total of 338 carotid
endarterectomies.
At the time of entry, a complete medical history was
taken and the following risk factors recorded: age,
gender, side of endarterectomy, clinical presentation
of carotid artery stenosis, degree of ipsilateral and
contralateral carotid stenosis, coronary artery disease
(angina pectoris, myocardial infarction, coronary
artery bypass grafting procedure or percutaneous
transluminal coronary angioplasty), diabetes mellitus
(patients on diet, oral hypoglycaemic agents or insu-
lin, or with fasting glucose levels 47 mmol/l), hyper-
cholesterolaemia (total cholesterol4 5.2 mmol/l),
hypertension (blood pressure greater than 160 mmHg
systolic and/or 95 mmHg diastolic) and smoking
habit (current or quit) (Table 1). Since patients' infor-
mation regarding smoking is generally unreliable, it
was always verified by asking their relatives. Median
age was 68 years (range 38±92 years). Median stenosis
of the operated and contralateral carotid artery was
80% (range 50±99%) and 60% (range 20±100%) respec-
tively. All patients with one or more risk factors were
aggressively treated through both pharmacological
(Table 2) and behavioural interventions (smoking
cessation, physical exercise, modification of diet,
coping with stress). The adequacy of treatment was
ensured by the regular follow-up.
The ultrasonographic characteristics of the plaques
were also recorded, with the plaques being divided
into five categories:1,2 111 (33%) were uniformly echo-
lucent (type I), 61 (18%) predominantly echolucent
(type II), 67 (20%) predominantly echogenic (type III)
and 99 (29%) uniformly echogenic, while we did not
encounter any type V plaques (plaques that cannot be
classified owing to heavy calcification and acoustic
shadows). Among the 30 patients who underwentTable 1. Baseline characteristics.
Characteristic No of pts %
Gender
Male 224 73
Female 84 27
Diabetes mellitus 95 31
Hypertension 238 77
Coronary artery disease 190 62
Hypercholesterolaemia 125 41
History of smoking 246 80
Eur J Vasc Endovasc Surg Vol 24, September 2002bilateral carotid endarterectomy, in 21 the plaque
type was the same bilaterally, in 8 it differed by
one category, in one it differed by two categories,
while none of these patients had plaque type I on
one side and type IV on the other.
In order to assure uniformity of the applied ultra-
sonographic criteria, B-mode images as well as
velocity recordings were kept and retrospectively
re-evaluated by the same examiner who was blinded
to the results of previous examinations and to the
clinical course of the disease. The intraobserver varia-
bility of the plaque characterisation was also assessed
during this process. Good agreement between two
separate assessments of plaque type was found, with
a k value of 0.67 (95% CI, 0.53±0.81). Over the past 5
years, continuing evaluation of the ultrasonographic
assessment was also performed through the partici-
pation of our institute in the ACSRS study.
Indications for operation were the asymptomatic
internal carotid artery stenosis of 470% in 68 (20%)
patients and the symptomatic stenosis of 450% in 270
(80%) patients. Among the symptomatic patients, 178
(66%) had history of transient ischaemic attacks (TIAs)
and 92 (34%) history of established stroke.
General anaesthesia was used in 314 (89%) out of
the 338 surgical procedures, while the remaining
24 (11%) were performed under local anaesthesia.
Conventional endarterectomy using a deep plane
was performed through a longitudinal arteriotomy
extending beyond the end of the plaque without use
of tacking sutures. Systemic heparinisation before
clamping with 5000 IU in a bolus dose was a standard
procedure. Heparin was not reverted to at the end of
the procedure. In all cases closure of the arteriotomy
was performed with a running 5-0 or 6-0 Prolene
suture (Ethicon Inc., Somerville, U.S.A.). Postopera-
tively, all patients received acetylsalicylic acid at a
dose of 100 mg/day. In order to exclude other factorsAntihypertensive drugs
Diuretics 64 21
Beta-blockers 140 45
Calcium channel blockers 100 32
ACE inhibitors 74 24
Antidiabetic drugs
Insulin 37 12
Oral hypoglycaemic drugs 58 19
Cholesterol-lowering drugs
Statins 57 19
Fibrates 3 1
Cholestyramine 47 15
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used (21 patients) and patients who were operated
on because of restenosis (4 patients) or post-radiation
arteritis (3 patients) were excluded from this study.
All of our patients were followed using colour
duplex ultrasonography one month after the endarter-
ectomy and every 6 months thereafter. The rationale of
the first duplex, which was performed one month
after the operation, was to detect residual disease,
while the rest of the ultrasonograms were performed
in order to detect recurrent stenosis. All scans were
performed by the same examiner with the use of
an ATL Interspec Apogee scanner with a 7.5 MHz
probe (Advanced Technologies Laboratories, Bothell,
Washington). Internal carotid artery stenosis
(expressed as the percentage decrease in artery diam-
eter) was estimated using Doppler spectral features:
ICA peak systolic velocity (PSV), end-diastolic
velocity (EDV) and ICA/CCA (common carotid
artery) PSV ratio,15 in combination with data derived
from the B-mode image (Table 3).
The main outcome measures were the development
of restenosis of more than 50%, the occurrence of car-
diovascular events and overall mortality. The criteria
used to define cardiovascular events and deaths were
adapted from those proposed by the American Heart
Association.16,17
The impact of the various risk factors on restenosis,
cardiovascular events and overall mortality was
assessed using the Kaplan±Meier method. Curves
depicting the cumulative freedom from restenosis,
cardiovascular events and overall deaths were drawn
for each variable and compared using the log rank test.
Pairwise comparisons between more than two curves,
as in the four-scale plaque type, were performed using
Bonferroni's correction. After determining univariate
associations, multivariate (Cox regression) analysis
was applied, in order to determine independence ofTable 3. Duplex criteria for grading ICA stenosis.15
Stenosis
%
PSV EDV PSVICA/
PSVCCA
0±29 PSV 100 EDV5 40
30±49 1005PSV5 130 EDV5 40
50±59 PSV4 130 EDV5 40 PSV
ratio5 3.2
60±69 PSV4 130 405EDV5 110 3.2PSV
ratio5 4
70±79 PSV4 210 1105EDV5 140 PSV
ratio 4
80±95 PSV4 210 EDV4 140 PSV
ratio 4
96±99 String flow
100 Absence of flow
PSV and EDV are in cm/s.associations. Since the carotid plaque type is a nom-
inal parameter with more than two categories, it
required transformation into a dummy parameter in
order to be used in the regression analysis. In this case,
uniformly echogenic plaques were used as the type of
reference. Results were considered statistically signi-
ficant when p-value was less than 0.05 or 0.007 after
Bonferroni's correction in the case of multiple compar-
isons between four curves.
Results
During the perioperative period, 8 patients (2.4%) had
a stroke or died. Three of our patients (0.9%) had
a transient ischaemic attack and 7 patients (2.1%) an
established stroke, two of whom died. One more
patient (0.3%) died on the third postoperative day
due to myocardial infarction, leading to a periopera-
tive mortality of 0.9%.
All of our patients were followed postoperatively
for 12±144 months (mean duration of follow-up: 63
months). Eight patients (2.6%) were lost to follow-up.
We have previously reported that the cumulative rest-
enosis rate in this group of patients at 10 years
of follow-up was 21.6%.14 With the addition of 310
patients-years of follow-up, 9 more patients were
found to have restenosis. The 10-year restenosis rate,
as calculated by life-table analysis, remained virtually
the same (21.2%) and so did the correlation between
restenosis rate and coronary artery disease ( p 0.01).
Hypercholesterolaemia, however, lost its prognostic
significance.
Kaplan±Meier method using the log rank test
showed that patients with uniformly echolucent pla-
ques had a significantly higher restenosis rate (25% at
7 years) as compared with patients with uniformly
echogenic plaques (3%) ( p5 0.001). The adverse effect
of plaque echolucency on carotid restenosis was also
evident when echogenicity grades 1 and 2 were
merged into one low echogenicity category and com-
pared with grades 3 and 4, merged into one high
echogenicity category (22 vs 5%) (p 0.005). The asso-
ciation proved to be independent of other risk factors
by multivariate analysis (p 0.02 for the comparison
between plaque types 1 and 4).
During the follow-up period, 44 of our patients had
one or more myocardial infarctions and 14 patients a
stroke. Two of these strokes were due to an ipsilateral
infarct, 4 to a contralateral infarct, 4 strokes were
lacunar and the remaining 4 haemorrhagic. No other
event such as aneurysm rupture or thromboembolism
occurred in any of our patients. Overall, cardiovascu-
lar events occurred in 56 patients (2 patients had bothEur J Vasc Endovasc Surg Vol 24, September 2002
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(66%). Other causes of death included cancer of the
large bowel (4), lung cancer (1), chronic obstructive
pulmonary disease (1), renal failure (1) and pul-
monary infection (1), while one patient died of
unknown cause. Cardiovascular events accounted
for 77% (37/48) of all deaths.
The 10-year freedom from cardiovascular events
was 59%, as estimated by life-table analysis. Univari-
ate analysis (Fig. 1) showed that patients with uni-
formly echolucent plaques had a significantly lower
survival free of cardiovascular events as compared
with patients with uniformly echogenic plaques
(p5 0.001). Plaque echolucency was also found to be
an indicator of poor prognosis, with respect to cardio-
vascular events, when the low echogenicity category
(plaque types I and II) was compared to the high
echogenicity category (plaque types III and IV)12010896847260483624120
Time (months)
Number at risk
101   92       70       58       41      29         19         13         11
56     43       35       30       19      11         11         10
61     60       52       43       33      21         13         10
90     89       83       77       71      61         49         34         19          12
Plaque type
I
   II
   III
   IV
1,0
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0
Fig. 1. Cumulative freedom from cardiovascular events with regard
to the ultrasonographic type of the carotid plaque.
Table 4. Results of Cox regression analysis with regard to the
occurrence of cardiovascular events.
Variable B Std error t Sig.
Age 0.027 0.020 1.830 0.18
Gender 0.154 0.395 0.152 0.70
History of stroke 0.708 0.391 3.289 0.06
Plaque type
Type I 1.005 0.385 6.821 0.01
Type II 0.191 0.352 0.294 0.59
Type III 0.424 0.432 0.967 0.33
Diabetes mellitus ÿ0.181 0.353 0.262 0.61
Hypertension 1.423 0.476 8.942 0.003
Coronary artery disease 1.462 0.473 9.572 0.002
Smoking 0.265 0.340 0.606 0.44
Hypercholesterolaemia ÿ0.580 0.359 2.619 0.11
Stenosis operated 0.006 0.010 0.342 0.56
Stenosis contralateral 0.025 0.014 3.312 0.07
Eur J Vasc Endovasc Surg Vol 24, September 2002( p 0.009). Among the rest of the risk factors, analysis
showed a significant association of cardiovascular
events with hypertension ( p 0.007) and CAD
( p5 0.001) and a borderline association with the
history of stroke (p 0.053).
Multivariate analysis (Table 4) verified that the
ultrasonographic characteristics of the plaques, coron-
ary artery disease and hypertension were independ-
ently associated with future cardiovascular events. On
the contrary, history of stroke was not found to be of
prognostic significance.
Actuarial survival rate at 10 years postoperatively
was 64%. Statistical analysis showed that the ultraso-
nographic characteristics of the carotid artery plaques
were not associated with overall survival.
Discussion
The identification and modification of factors predis-
posing to cardiovascular events has always been a
point of great importance. Nowadays, the role of
factors such as hypertension, cigarette smoking,
diabetes mellitus and hyperlipidaemia in causing
atherosclerosis has been proven beyond any doubt.
In this context, our finding that smoking, diabetes
mellitus and hypercholesterolaemia were not asso-
ciated with future cardiovascular events in patients
submitted to carotid endarterectomy seems strange.
However, it should be noted that the material of our
study was patients with already known atheroscler-
osis and not the general population. Therefore, com-
parisons are made between a group of patients with
a specific risk factor and the rest of the patients
who also have atherosclerosis, due to other reasons.
In addition, the development of atherosclerosis is a
chronic process that is caused, or at least accelerated,
by the before-mentioned conventional risk factors,
whereas the risks of the major thrombotic and throm-
boembolic complications of atherosclerosis appear to
be related more to the stability of atheromatous pla-
ques than to the extent of disease.18
Several studies have been published supporting the
theory that echolucent carotid plaques are more prone
to rupture and therefore to the development of cere-
brovascular symptoms.2±9 Our study is the first to
suggest an association between plaque echolucency
in the carotid arteries and plaque instability and rup-
ture in the coronary arteries. The co-existence of
unstable atheromatous plaques in certain individuals
implies that the development of plaque instability and
rupture is not related simply to local risk factors or to
chance; it is rather influenced by systemic factors,
which are present in these individuals. Rothwell
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the irregularity of the carotid plaque surface in asso-
ciation with previous myocardial infarction and future
non-stroke vascular death.
In our study, echolucent plaques were also found to
be associated with an increased risk of stenosis recur-
rence. This finding suggests that the effect of the
factors determining the `` active'' echolucent plaque is
chronic and not altered by the resection of the specific
atheromatous plaque.
Interestingly, the only difference that was detected
both for cardiovascular events as well as for restenosis
was between the two extreme types of plaques (I and
IV). One might have thought that also type II is asso-
ciated with an increased risk or that there is a linear
association between plaque type and these events. The
fact that we were unable to show such a correlation
may either mean that such an association does not
exist or that the number of patients in the intermediate
groups (plaque types II and III) or the years of follow-
up were inadequate to detect slight differences
between these groups. In our series, uniformly echo-
lucent plaques were the most commonly found plaque
type, which was rather expected since most of our
patients (80%) were symptomatic.
In support of the theory of systemic factors influen-
cing the development of specific plaque types, most of
our patients who were submitted to bilateral carotid
endarterectomy had the same plaque type on both
sides. Biologic variability, intraobserver variability as
well as local factors may account for the differences in
plaque type found in the remaining patients.
Another finding that initially seems strange is that,
while the ultrasonographic characteristics of the
carotid artery plaques were associated with the devel-
opment of future cardiovascular events, they were not
associated with overall mortality. However, it should
be noted that only 37 out of the 56 patients who had
a cardiovascular event eventually died during the
follow-up period. Nine more patients who died of
non-vascular causes were added to these 37 patients
and, as a result, statistical significance was lost.
Undoubtedly, a key issue in all studies examining
the ultrasonographic characteristics of the carotid
artery plaques is the reproducibility of this subjective
and qualitative classification. By having the same,
experienced examiner evaluating all of the B-mode
images at the same time point, we were able to obtain
a k value of 0.67, indicating good agreement between
two separate evaluations. We were unable, however,
to reproduce k values of as high as 0.7319 or 0.792
reported in the literature, maybe due to the use of
hard copies instead of digital images.20 On the other
hand, the variability of our assessment comparesfavorably with reports of k values ranging from
0.28 to 0.6111,20±22 and allowed us to proceed with the
statistical evaluation of these data.
In conclusion, the 10-year restenosis rate following
carotid endarterectomy was 21.2%, the 10-year sur-
vival 64% and the 10-year rate of cardiovascular
events 41%. Uniformly echolucent plaques were asso-
ciated with both a higher incidence of restenosis
( p 0.02) and future cardiovascular events ( p 0.01)
as compared to uniformly echogenic plaques. These
findings suggest that patients with echolucent plaques
are in need of frequent monitoring and rigorous
follow-up together with modification of risk factors.
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